| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_867ce86b8e03631389dea87a9f5ca2ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8f12cf0dcf29ad96f37bee4842a0155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af3e414b2e1656b059cd37005db59c75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad4e011b87128d7809ed676ceaefd1a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9da281f34ca12cd68c8358623884db4c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate |
2004-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a9f053f338b6f4d781b6ca275815f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca8969b43ac1ce69778042192c30b0d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5734aa76a7442d355a27aa5fcd37cef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_083c84869e89a7d491739996e7218bed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c68af50a058f223cf2f5b09087da0952 |
| publicationDate |
2005-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005034868-A2 |
| titleOfInvention |
Methods for treating igf1r-inhibitor induced hyperglycemia |
| abstract |
Methods for treating cancer using IGF1R inhibitors in combination with insulin sensitizers are provided for the treatment or prevention of hyperglycemia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013110585-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9777018-B2 |
| priorityDate |
2003-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |